Aids-vaccine drug-giant signs deal

The global push to develop an Aids vaccine was boosted today by the first alliance between a major drug-maker and the non-profit sector to tackle the disease.

Pharmaceuticals giant GlaxoSmithKline has signed a deal with the International Aids Vaccine Initiative (IAVI) to research and develop a vaccine.